Enhanced Physiological Microenvironment for Improved Evaluation of Nanoparticle Behavior by unknown
Enhanced Physiological Microenvironment for Improved 
Evaluation of Nanoparticle Behavior
Emily K. Breitner 
Advisor: Kristen K. Comfort, Ph.D. and Saber M. Hussain, Ph.D.
Department of Chemical and Materials Engineering, University of Dayton
Rationale
• Nanoparticles (NPs) are being incorporated into
numerous products and applications.
• Thus, the safety of NPs needs to be evaluated.
• Both standard in vitro and in vivo methodologies
pose significant concerns, giving rise to the need
for an enhanced in vitro microenvironment for




• NP characteristics and the nano-bio interface are highly
dependent upon environmental composition and flow patterns.
• AAF caused increased agglomeration and deposition.





Fig 7: Deposition 
efficiency of 
AuNPs
Fig 9: Visualization of the nano-bio 
interface. A-D: Static; E-H: Dynamic; 
A,C,E,G: Media; B,D,F,H: AAF;       
C,D,G,H: with AuNPs





Dynamic Flow ExposureStatic Exposure




• A549 human alveolar 
epithelial cells





Fig 2: Establishment 
of dynamic flow 
through the use of a 
peristaltic pump
Fig 3: TEM image 
of 60 nm TA 
coated AuNPs
Fig 4: Spectral 
signature of 
AuNPs in various 
fluids
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Fig 5: Agglomerate 
sizes of AuNPs














































Fig 6: Rates of 

























Fig 8: TEM image 
of AuNP uptake 
(static, AAF)
